Information Update - Unauthorized natural health products including "SmartBrain Formulations" and "Cutting Edge Naturals" sold by Robert Lamberton Consulting may pose health risks
OTTAWA, Dec. 13, 2017 /CNW/ - Further to a recent Health Canada advisory about an unauthorized health product, "SmartBrain Formulations Serotonin Support," Health Canada is expanding its advisory to warn that all products sold by the company may pose serious health risks. These products are considered to be manufactured under unsanitary conditions at a site that is not licensed by Health Canada. Health Canada has seized all the products and manufacturing equipment that were found at the site.
The company operates under several names: Robert Lamberton Consulting; Cutting Edge Naturals; and Cutting Edge Nutraceuticals. It sells various products and custom formulations which are promoted for a variety of health issues and were being offered for sale online and by email. This includes products sold under the brand names "SmartBrain Formulations" and "Cutting Edge Naturals" which have not been authorized for sale in Canada.
Health Canada inspectors observed dirty manufacturing surfaces and equipment, and ingredients that were being stored in unsealed containers. Unsanitary manufacturing conditions can lead to issues such as bacterial contamination, which can pose serious health risks, especially for those with a weakened immune system. Health Canada issued the advisory about SmartBrain Formulations Serotonin Support after testing found E. coli contamination, which can cause serious health problems such as severe stomach cramps, profuse watery or bloody diarrhea, vomiting, nausea and headache.
One product, "Neuroactin Plus Pro" (NPN 80063407 held by Robert Lamberton Consulting), is licensed by Health Canada and appears to have also been manufactured at this site. Health Canada has suspended this product licence, which means no person can legally sell this product.
What you should do
Stop using products manufactured by this company (Robert Lamberton Consulting; Cutting Edge Naturals; and Cutting Edge Nutraceuticals) and consult a health care professional with any questions or concerns.
Read product labels to verify that health products have been authorized for sale by Health Canada. Authorized health products have an eight-digit Drug Identification Number (DIN), Natural Product Number (NPN) or Homeopathic Drug Number (DIN-HM). You can also check whether products have been authorized for sale by searching Health Canada's Drug Product Database and Licensed Natural Health Product Database.
Report adverse events to health products to Health Canada by calling toll-free at 1 866 234 2345, or by reporting online, by mail or by fax.
Report complaints about health products to Health Canada by calling toll-free at 1 800 267 9675, or complete an online complaint form.
Health Canada will take further action as necessary to mitigate any risks to the health of Canadians and inform Canadians as appropriate.
The global gastroesophageal reflux disease (GERD) market size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of 3.2% during the forecast period. Rising geriatric...
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.
Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...